Tag
5 articles
This article explains how artificial intelligence (AI) is revolutionizing the pharmaceutical industry by helping scientists discover new medicines faster. It explores the concept of AI pharma and how a major tech company invested $400 million in a tiny AI startup developing new treatments.
Anthropic has acquired Coefficient Bio, a stealth biotech startup founded just eight months ago, in a $400 million all-stock deal. The acquisition brings in a team of fewer than 10 former Genentech researchers, signaling Anthropic's expansion into healthcare AI.
Dutch biotech Laigo Bio has raised €17 million in seed funding to advance its innovative SureTACs platform, which targets previously 'undruggable' membrane proteins through protein degradation.
Ysios Capital launches a €100 million fund, InceptionBio, to support early-stage biotech companies created from Spanish academic research.
German biotech Kupando has raised €10M to advance its innate immunity drug KUP101 into human clinical trials, targeting solid tumors and drug-resistant infections.